483 Taizhou Kangping Medical Science And Technology Mar 2019

483 Taizhou Kangping Medical Science And Technology Mar 2019

Jonathan Chapman FDA$119.00 - Available Now

FDA investigators audited the Taizhou Kangping Medical Science And Technology - Taizhou, China facility and issued inspectional observations (via FDA 483) on 07 Mar 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 07 Mar 2019
  • Location: Taizhou, China
  • FEI: 3013321339
Add To Cart